Vanessa F. Mosqueira

Ouro Preto, MG, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Corrigendum to "Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells" [Biomed. Pharmacother. 134 (2021) 111114].

Corrigendum to "Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells" [Biomed. Pharmacother. 134 (2021) 111114].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 02, 2026

Drug Combination in Polymeric Nanocarriers for Chemotherapy of Cancer: Preclinical Outcomes in the Last Ten Years.

Drug Combination in Polymeric Nanocarriers for Chemotherapy of Cancer: Preclinical Outcomes in the Last Ten Years.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 11, 2025

Albaconazole Polymeric Nanocapsules for Treating Trypanosoma cruzi Infections.

Albaconazole Polymeric Nanocapsules for Treating Trypanosoma cruzi Infections.

Journal: Pathogens (Basel, Switzerland)

Published: February 04, 2025

Development and Characterization of Innovative Nifurtimox Formulations as Therapeutic Alternative for Chagas Disease.

Development and Characterization of Innovative Nifurtimox Formulations as Therapeutic Alternative for Chagas Disease.

Journal: Tropical medicine and infectious disease

Published: December 26, 2024

Impact of non-ionic surfactants on release kinetics, toxicity and colloidal characteristics of benznidazole self-emulsifying delivery system evidenced by flow field-flow fractionation.

Impact of non-ionic surfactants on release kinetics, toxicity and colloidal characteristics of benznidazole self-emulsifying delivery system evidenced by flow field-flow fractionation.

Journal: Journal of chromatography. A

Published: September 15, 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status.

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status.

Journal: Expert opinion on investigational drugs

Published: April 30, 2024

Screening of synthetic 1,2,3-triazolic compounds inspired by SRPIN340 as anti-Trypanosoma cruzi agents.

Screening of synthetic 1,2,3-triazolic compounds inspired by SRPIN340 as anti-Trypanosoma cruzi agents.

Journal: Revista da Sociedade Brasileira de Medicina Tropical

Published: December 17, 2023

Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.

Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.

Journal: Vaccines

Published: April 26, 2023

Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.

Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.

Journal: Experimental parasitology

Published: April 04, 2023

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment.

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment.

Journal: Pharmaceutics

Published: December 21, 2022

Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster

Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster

Journal: Vaccines

Published: November 14, 2022

Polyester Nanocapsules for Intravenous Delivery of Artemether: Formulation Development, Antimalarial Efficacy, and Cardioprotective Effects In Vivo.

Polyester Nanocapsules for Intravenous Delivery of Artemether: Formulation Development, Antimalarial Efficacy, and Cardioprotective Effects In Vivo.

Journal: Polymers

Published: November 01, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026